| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |